Science

Semaglutide, the medicine behind Ozempic and Wegovy, has been found to have significant benefits for heart health. Recent data from the largest and longest clinical trial on semaglutide use amongst those without diabetes, known as the Semaglutide and Cardiovascular Outcomes (SELECT) trial, has shown promising results. The study involved approximately 17,600 overweight or obese adults
0 Comments
Adenomyosis, a chronic condition affecting the uterus, remains largely unknown to many despite its prevalence among women. BBC presenter Naga Munchetty’s personal battle with this condition shed light on the debilitating symptoms, including irregular and heavy menstrual bleeding, pelvic pain, and fertility issues. What causes adenomyosis, how is it diagnosed, and what treatment options are
0 Comments